Double blind, randomised cross-over trial of the efficacy of cranial electrotherapy stimulation on pain in fibromyalgia

Not Applicable

Recruiting

• Conditions: Fibromyalgia; Alternative and Complementary Medicine - Other alternative and complementary medicine; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12609000711213
• Lead Sponsor: Pacific Medistim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Person's diagnosed with Fibromyalgia

Exclusion Criteria

Persons under 18.
Pregnant women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Reduction<br><br>This outcome measures will be measured by tenderpoint count, visual analogue scales and self-report Fibromyalgia Impact Questionnaire (FIQ)[Baseline, 3 weeks and 6 weeks.]

Secondary Outcome Measures

Name	Time	Method
Anxiety Reduction)<br><br>Measured by Depression and Anxiety Symptoms questionnaire (DAS) and the Inventory of Depressive Symptoms (IDS)[Baseline, 3 weeks and 6 weeks.];Reduction of Insomnia<br><br>Quality of sleep measured by the Pittsburg Sleep Inventory[Baseline, 3 weeks and 6 weeks.];Impact of Illness - Fibromyalgia Impact Questionnaire[Baseline, 3 weeks and 6 weeks.];Reduction in Depressive Symptoms<br><br>Depression measured by Depression and Anxiety Symptoms questionnaire (DAS) and the Inventory of Depressive Symptoms (IDS)[Baseline, 3 weeks and 6 weeks.]